SR9009 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-05-29 and is reviewed periodically as new material appears.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
== Pharmacology == Dantrolene depresses excitation-contraction coupling in skeletal muscle by acting as a receptor antagonist to the ryanodine receptor, and decreasing free intracellular calcium concentration.
One method of doing this is to simply have the pyruvate do the oxidation; in this process, pyruvate is converted to lactate (the conjugate base of lactic acid) in a process called lactic acid fermentation:
When SWAPO's executive committee proved unable to suppress the PLAN revolt, the Zambian National Defence Force (ZNDF) mobilised several army battalions and attacked the camps held by the mutineers, rounding up an estimated 1,800 PLAN dissidents. SWAPO's Secretary for Information, Andreas Shipanga, was found responsible by the Zambian government for inciting the revolt. Zambian president Kenneth Kaunda deported Shipanga and several other high-ranking dissidents to Tanzania, while incarcerating the others at remote army facilities. Sam Nujoma accused them of being South African agents and carried out a purge of the surviving political leadership and PLAN ranks. Forty mutineers were formally sentenced to death by a PLAN tribunal in Lusaka, and hundreds of others were subject to enforced disappearances. Additionally, the heightened tension between Kaunda's government and PLAN resulted in the ZNDF confiscating PLAN arms caches. The fallout from the Shipanga Affair prompted PLAN to relocate its headquarters from Lusaka to Lubango, Angola, at the invitation of the MPLA. It was joined shortly afterwards by SWAPO's political wing, which relocated to Luanda. SWAPO's closer affiliation and proximity to the MPLA may have influenced its concurrent slide to the left; the party adopted a more overtly Marxist discourse, such as a commitment to a classless society based on the ideals and principles of scientific socialism. From 1976 onward, SWAPO considered itself the ideological as well as the military ally of the MPLA.
monosaccharide Any of a class of organic compounds which are the simplest forms of carbohydrates and the most basic structural subunits or monomers from which larger carbohydrate polymers such as disaccharides, oligosaccharides, and polysaccharides are composed. With few exceptions, all monosaccharides are variations on the empirical formula (CH2O)n, where n typically ranges from 3 (trioses) to 7 (heptoses). Common examples include glucose, ribose, and deoxyribose.
Sources: en.wikipedia.org
By September 1604, Dmitri I had gathered a force of 2,500 men, of whom 1,400 were Cossacks. Two thirds of these "cossacks", however, were in fact Ukrainian civilians, only 500 being professional Ukrainian Cossacks. On July 4, 1610, 4,000 Ukrainian Cossacks fought in the Battle of Klushino, on the side of the Polish-Lithuanian Commonwealth. They helped to defeat a combined Muscovite-Swedish army and facilitate the occupation of Moscow from 1610 to 1611, riding into Moscow with Stanisław Żółkiewski. The final attempt by King Sigismund and Wladyslav to seize the throne of Muscovy was launched on April 6, 1617. Although Wladyslav was the nominal leader, it was Jan Karol Chodkiewicz who commanded the Commonwealth forces. By October, the towns of Dorogobuzh and Vyazma had surrendered. But a defeat, when the counterattack on Moscow by Chodkiewicz failed between Vyasma and Mozhaysk, prompted the Polish-Lithuanian army to retreat. In 1618, Petro Konashevych-Sahaidachny continued his campaign against the Tsardom of Russia on behalf of the Cossacks and the Polish-Lithuanian Commonwealth. Numerous Russian towns were sacked, including Livny and Yelets. In September 1618, with Chodkiewicz, Konashevych-Sahaidachny laid siege to Moscow, but peace was secured.
Microsomal glutathione S-transferase 2 is an enzyme that in humans is encoded by the MGST2 gene. The MAPEG (Membrane-Associated Proteins in Eicosanoid and Glutathione metabolism) family consists of six human proteins, several of which are involved in the production of leukotrienes and prostaglandin E, important mediators of inflammation. This gene encodes a protein that catalyzes the conjugation of leukotriene A4 and reduced glutathione to produce leukotriene C4.
The first β-sheet structure was proposed by William Astbury in the 1930s. He proposed the idea of hydrogen bonding between the peptide bonds of parallel or antiparallel extended β-strands. However, Astbury did not have the necessary data on the bond geometry of the amino acids in order to build accurate models, especially since he did not then know that the peptide bond was planar. A refined version was proposed by Linus Pauling and Robert Corey in 1951. Their model incorporated the planarity of the peptide bond which they previously explained as resulting from keto-enol tautomerization.
During the course of World War I and the Turkish War of Independence, Turkish authorities enslaved over 500,000 Armenians and Greeks—primarily men, but also women and children—into labour battalions, as part of the Armenian genocide and the Greek genocide. Enslaved people forced into labour battalions often died quickly and under crippling conditions in quarries, mines, and roads, or were killed by their Turkish guards. In 1921, Turkish authorities made false birth certificates declaring Greek orphans to be older than they actually were. In this way, children were also conscripted into labour battalions. In 1922, Herbert Adams Gibbons relayed a report by the Near East Relief to the U.S. Secretary of State Charles Evans Hughes, which warned that the Greeks were in a condition "worse than slavery", while Mark Lambert Bristol reported that the Greek men in labour battalions were "treated like animals." The brutal conditions in these battalions resulted in a very high death rate among victims, reaching from 80% to as high as 99%.
Pepino, a refreshing and thirst-quenching fruit, was eaten by common folk, but scorned by "pampered folk" and was considered difficult to digest. Another fruit that was available to the Incas was the passion fruit (Passiflora spp.) which was actually named so by the Spanish conquistadors and explorers due to the claim that the flowers of the plant contained the symbols of the passion of Christ. The fruit itself is like a pomegranate as they both have a mass of seeds covered by juicy flesh. A fruit that was described as an interesting snack available in the Andes during the time of the Inca Empire was the paqay (Inga feuilleei), or the guaba, which was known for its sweet, spongey substance that covers its seeds. A lesser valued fruit within Inca cuisine was the lúcuma (Lucuma bifera) which was difficult to consume and had little flavor. Opposite to the lucuma in popularity, due to their tender texture and the sweet juice they produce, were the almonds within Caryocar amygdaliferum of the Chachapoyas. They were luxury goods for many generations as many have been found within early tombs of the region.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.